2013 Fiscal Year Final Research Report
Development of new remedy for pulmonary fibrosis, focused on HB-EGF
Project/Area Number |
23591171
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Fukuoka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
UCHINO Junji 福岡大学, 医学部, 講師 (80432946)
|
Co-Investigator(Renkei-kenkyūsha) |
TASHIRO Naoki 福岡大学, 医学部, 助教 (70613884)
|
Project Period (FY) |
2011 – 2013
|
Keywords | 肺線維症 / HB-EGF |
Research Abstract |
The aim of this study is to clarify the role of HB-EGF in respiratory diseases, especially pulmonary fibrosis and to develop new remedy for pulmonary fibrosis. The expression of HB-EGF was elevated in the bleomycin induced pulmonary fibrosis in inflammation phase. Then the expression was decreased in fibrosis phase. The HB-EGF expression was down-regulated in clinical specimen from the idiopathic pulmonary fibrosis. Therefore, it was revealed that the expression of HB-EGF was down-regulated related to pulmonary fibrosis. We hypothesized that overexpression of HB-EGF might lead to rescue of pulmonary fibrosis. We administered of adenovirus vector of HB-EGF expression or recombinant HB-EGF into bleomycin induced pulmonary fibrosis model. However, the apparent attenuation was not attained. As a result, the expression of HB-EGF was down-regulated in pulmonary fibrosis, but overexpression of HB-EGF did not result in attenuation of pulmonary fibrosis in this study.
|